PBMs oppose US FTC request for January 2026 admin trial in insulin antitrust case
MLex Summary: Caremark Rx, Express Scripts, OptumRx and other firms facing antitrust claims from the US Federal Trade Commission over insulin prices told an agency administrative law judge that delaying an...To view the full article, register now.
Already a subscriber? Click here to view full article